Skip to main content
BKD
NYSE Life Sciences

Brookdale Senior Living Reports Q1 Adjusted EBITDA Miss, Revenue Falls

feedReported by Reuters
Sentiment info
Negative
Importance info
7
Price
$13.51
Mkt Cap
$3.372B
52W Low
$6.07
52W High
$17.09
Market data snapshot near publication time

summarizeSummary

Brookdale Senior Living reported Q1 adjusted EBITDA of $131.10 million, missing analyst expectations of $136.48 million, and revenue fell 7% year-over-year primarily due to community dispositions. While the company's net loss significantly narrowed to $7 million from $65 million a year prior, the miss on a key profitability metric like adjusted EBITDA is a material negative for investors. The company reiterated its full-year 2026 RevPAR growth guidance of 8% to 9% and provided full-year adjusted EBITDA guidance of $502 million to $516 million, noting April occupancy trends are on track. Investors will closely watch future occupancy trends, cost management, and the company's execution on its reiterated guidance.

At the time of this announcement, BKD was trading at $13.51 on NYSE in the Life Sciences sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $6.07 to $17.09. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed BKD - Latest Insights

BKD
May 06, 2026, 5:10 PM EDT
Source: Reuters
Importance Score:
7
BKD
May 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
BKD
Apr 08, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
BKD
Feb 19, 2026, 4:19 PM EST
Filing Type: 10-K
Importance Score:
8
BKD
Feb 18, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
8
BKD
Jan 28, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
8
BKD
Jan 12, 2026, 7:34 AM EST
Filing Type: 8-K
Importance Score:
8